Additional file 2: Table S2 Differential IC50s observed for 168 drugs in two group
Figure S2. Heatmap with Top 50 Significantly Probes with Drug response (Three Levels) in Terragna et...
Figure S1. A Meta-analysis of 4 different GEP datasets of MM comparing the expression levels of gene...
Additional file 9: Supplementary Table 4. Specific marker genes of malignant plasma cell subclones i...
Additional file 5: Figure S2 Assessment of the prognostic risk signature in GSE136337. A The distrib...
Additional file 6: Figure S3 Assessment of the prognostic risk signature. A K-M survival analysis in...
Additional file 4: Figure S1 Assessment of the prognostic risk signature in TCGA. A The distribution...
Abstract Background About 10% of hematologic malignancies are multiple myeloma (MM), an untreatable ...
Additional file 7: Figure S4 Effects of Nelarabine, Carmustine and Temozolomide on apoptotic death, ...
Additional file 2: Fig. S1. The correlation between the lactate metabolism-related gene signatures a...
List of mRNAs co-expressed with at least one of the four prognostic lncRNAs. (XLS 131Â kb
Background: Lactate, an intermediate product of glycolysis, has become an essential regulator of tum...
List of enriched GO terms and KEGG pathways of mRNAs co-expressed with prognostic lncRNAs. (XLS 72Â ...
Background: Lactate, an intermediate product of glycolysis, has become an essential regulator of tum...
Background: Lactate, an intermediate product of glycolysis, has become an essential regulator of tum...
Figure S1. Heatmap with Top 50 Significantly Probes with Drug response (Three Levels) in Mulligan et...
Figure S2. Heatmap with Top 50 Significantly Probes with Drug response (Three Levels) in Terragna et...
Figure S1. A Meta-analysis of 4 different GEP datasets of MM comparing the expression levels of gene...
Additional file 9: Supplementary Table 4. Specific marker genes of malignant plasma cell subclones i...
Additional file 5: Figure S2 Assessment of the prognostic risk signature in GSE136337. A The distrib...
Additional file 6: Figure S3 Assessment of the prognostic risk signature. A K-M survival analysis in...
Additional file 4: Figure S1 Assessment of the prognostic risk signature in TCGA. A The distribution...
Abstract Background About 10% of hematologic malignancies are multiple myeloma (MM), an untreatable ...
Additional file 7: Figure S4 Effects of Nelarabine, Carmustine and Temozolomide on apoptotic death, ...
Additional file 2: Fig. S1. The correlation between the lactate metabolism-related gene signatures a...
List of mRNAs co-expressed with at least one of the four prognostic lncRNAs. (XLS 131Â kb
Background: Lactate, an intermediate product of glycolysis, has become an essential regulator of tum...
List of enriched GO terms and KEGG pathways of mRNAs co-expressed with prognostic lncRNAs. (XLS 72Â ...
Background: Lactate, an intermediate product of glycolysis, has become an essential regulator of tum...
Background: Lactate, an intermediate product of glycolysis, has become an essential regulator of tum...
Figure S1. Heatmap with Top 50 Significantly Probes with Drug response (Three Levels) in Mulligan et...
Figure S2. Heatmap with Top 50 Significantly Probes with Drug response (Three Levels) in Terragna et...
Figure S1. A Meta-analysis of 4 different GEP datasets of MM comparing the expression levels of gene...
Additional file 9: Supplementary Table 4. Specific marker genes of malignant plasma cell subclones i...
DOI
Add to ORKG